Dual-layer detector spectral CT for predicting p16 status in head and neck squamous cell carcinoma

被引:1
|
作者
Li, Zhijun [1 ,2 ,3 ,4 ]
Ye, Lu [1 ,2 ,3 ,4 ]
Xiao, Jianyu [1 ,2 ,3 ,4 ]
Lu, Xiaomei [5 ]
Ye, Zhaoxiang [1 ,2 ,3 ,4 ]
机构
[1] Tianjin Med Univ, Dept Radiol, Canc Inst & Hosp, Tianjin, Peoples R China
[2] Tianjin Med Univ Canc, Natl Clin Res Ctr Canc, Inst & Hosp, Tianjin, Peoples R China
[3] Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China
[4] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China
[5] Philips Healthcare, CT Clin Sci CT, Shenyang, Peoples R China
关键词
Head and neck squamous cell carcinoma; Spectral CT; HPV; p16; Quantitative analysis; HUMAN-PAPILLOMAVIRUS; SURVIVAL;
D O I
10.1007/s42058-023-00123-y
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BackgroundHPV-positive head and neck squamous cell carcinoma (HNSCC) differs from HPV-negative HNSCC in clinical features, biological behavior, pathological manifestations, cytogenetics and tend to have better outcome. Immunohistochemical (IHC) p16 staining is highly sensitive for HPV status exam, but has a certain probability of false positives, and the accurate result of p16 expression could be challenging due to the limitation of the biopsy location and quantity. As a non-invasive approach, dual-layer detector spectral CT (DLSCT) provides multi-parameter quantitative analysis, which could help better reflect the changes of tumor characteristics. Hence, this study aimed to evaluate the spectral-derived differences between the p16( +) and p16(-) group of HNSCC so as to explore the application in preoperative diagnosis in differentiating the p16 expression status of HNSCC.Materials and methodsThe spectral data of 35 patients with biopsy confirmed HNSCC were retrospectively analyzed and compared between p16( +) (n = 11) and p16(-) (n = 25) group. All statistical analyses were performed on SPSS v26.0.ResultsEffective atomic number (Zeff), slope value of virtual monoenergetic image (VMI), and normalized iodine density (NID) of p16( +) group were all significantly lower than p16(-) group (8.36 (8.24, 8.42) vs. 8.57 (8.38, 8.85), 2.45 (2.22, 2.64) vs. 3.06 (2.50, 3.82), 0.43 & PLUSMN; 0.09 vs. 0.55 & PLUSMN; 0.14, respectively) (p < 0.05). Besides, NID showed a good ability to discriminate p16(-) HNSCC from p16( +) HNSCC (AUC = 0.788) with a threshold value of 0.495.ConclusionDLSCT could be helpful for the differentiation of p16 expression in HNSCC.
引用
收藏
页码:116 / 121
页数:6
相关论文
共 50 条
  • [21] Usefulness of dual-layer spectral CT in follow-up examinations: diagnosing recurrent squamous cell carcinomas in the head and neck
    Takumi, Koji
    Hakamada, Hiroto
    Nagano, Hiroaki
    Fukukura, Yoshihiko
    Kumagae, Yuichi
    Sakai, Osamu
    Yoshiura, Takashi
    JAPANESE JOURNAL OF RADIOLOGY, 2021, 39 (04) : 324 - 332
  • [22] Iodine Imaging at Spectral CT with a Dual-Layer Detector
    Ozguner, O.
    Dhanantwari, A.
    Halliburton, S.
    Wen, G.
    Utrup, S.
    Jordan, D.
    MEDICAL PHYSICS, 2016, 43 (06) : 3657 - 3657
  • [23] CD44 Expression Is Correlated With MTOR Expression And p16 Status In Head And Neck Squamous Cell Carcinoma
    Arden, J. D.
    Quinn, T. J.
    Wilson, T. G.
    Hanna, A.
    Baschnagel, A. M.
    Wilson, G. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E505 - E505
  • [24] Prognostic Value of P16 Status for Head and Neck Squamous Cell Carcinoma of Unknown Primary Treated With Definitive Chemoradiation
    Lu, S. M.
    Chen, J.
    Lien, W. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E297 - E297
  • [25] The prognostic value of tumour p16 status in non-oropharyngeal head and neck squamous cell carcinoma.
    Chee, Lessandra Y. S.
    Huang, Shao Hui
    Su, Jie
    Weinreb, Ilan
    Perez-Ordonez, Bayardo
    Bratman, Scott
    Cho, John
    Hahn, Ezra
    Hope, Andrew
    Hosni, Ali
    Kim, John
    McPartlin, Andrew
    O'Sullivan, Brian
    Ringash, Jolie
    Tsai, C. Jillian
    de Almeida, John
    Yao, Christopher M. K. L.
    Garcia, Enrique Sanz
    Tong, Li
    Waldron, John
    RADIOTHERAPY AND ONCOLOGY, 2024, 192 : S101 - S103
  • [26] p16 Protein Expression and Human Papillomavirus Status As Prognostic Biomarkers of Nonoropharyngeal Head and Neck Squamous Cell Carcinoma
    Chung, Christine H.
    Zhang, Qiang
    Kong, Christina S.
    Harris, Jonathan
    Fertig, Elana J.
    Harari, Paul M.
    Wang, Dian
    Redmond, Kevin P.
    Shenouda, George
    Trotti, Andy
    Raben, David
    Gillison, Maura L.
    Jordan, Richard C.
    Quynh-Thu Le
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (35) : 3930 - U212
  • [27] Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1
    Beck, Tim N.
    Smith, Chad H.
    Flieder, Douglas B.
    Galloway, Thomas J.
    Ridge, John A.
    Golemis, Erica A.
    Mehra, Ranee
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (03): : E34 - E39
  • [28] The roles of PTEN, cMET, and p16 in resistance to cetuximab in head and neck squamous cell carcinoma
    Alexandre A. B. A. da Costa
    Felipe D’Almeida Costa
    Daniel Vilarim Araújo
    Marcos Pedro Guedes Camandaroba
    Victor Hugo Fonseca de Jesus
    Audrey Oliveira
    Ana Caroline Fonseca Alves
    Carlos Stecca
    Larissa Machado
    Andrea Cruz Feraz de Oliveira
    Thiago Bueno de Oliveira
    Ulisses Ribaldo Nicolau
    Vladmir Cláudio Cordeiro de Lima
    Medical Oncology, 2019, 36
  • [29] p16 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma: Association With Prognostic Parameters
    Hashmi, Atif A.
    Younus, Naila
    Naz, Samreen
    Irfan, Muhammad
    Hussain, Zubaida
    Shaikh, Sara T.
    Ali, Javaria
    Faridi, Naveen
    Najam, Javeria
    Shoaib, Maira
    Hashmi, Shumaila K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [30] IS P16 IMMUNOHISTOCHEMISTRY A SURROGATE FOR THE PRESENCE OF AN HPV INFECTION IN HEAD AND NECK SQUAMOUS CELL CARCINOMA?
    Weynand, B.
    Vanhaebost, J.
    Guiot, Y.
    Gregoire, V.
    Machiels, J. P.
    Reychler, H.
    Hamoir, M.
    RADIOTHERAPY AND ONCOLOGY, 2011, 98 : S10 - S10